Production (Stage)
Mydecine Innovations Group Inc.
MYCO
CNSX
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 6.80K | 200.00 | 44.50K | 9.90K | 15.00K |
Total Receivables | -- | 34.90K | 87.40K | 105.90K | 128.30K |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -- | -- | -- | -- | 14.20K |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 6.80K | 35.20K | 132.00K | 115.80K | 157.60K |
|
|||||
Total Current Assets | 6.80K | 35.20K | 132.00K | 115.80K | 157.60K |
Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | 6.80K | 35.20K | 132.00K | 115.80K | 157.60K |
|
|||||
Total Accounts Payable | 1.59M | 1.82M | 5.26M | 4.29M | 3.13M |
Total Accrued Expenses | 4.10M | 3.79M | 2.95M | 2.63M | 2.25M |
Short-term Debt | 170.40K | 166.90K | 168.50K | 163.90K | 161.50K |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 4.71M | 4.61M | 4.66M | 4.33M | 4.10M |
Total Finance Division Other Current Liabilities | 25.20K | 25.80K | -- | -- | -- |
Total Other Current Liabilities | 25.20K | 25.80K | -- | -- | -- |
Total Current Liabilities | 10.60M | 10.41M | 13.05M | 11.41M | 9.64M |
|
|||||
Total Current Liabilities | 10.60M | 10.41M | 13.05M | 11.41M | 9.64M |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | 170.40K | 166.90K | 168.50K | 163.90K | 161.50K |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 10.60M | 10.41M | 13.05M | 11.41M | 9.64M |
|
|||||
Common Stock & APIC | 99.53M | 99.43M | 105.89M | 104.52M | 105.61M |
Retained Earnings | -110.32M | -109.99M | -119.02M | -116.02M | -115.30M |
Treasury Stock & Other | 198.80K | 198.60K | 211.50K | 208.80K | 211.00K |
Total Common Equity | -10.59M | -10.37M | -12.91M | -11.29M | -9.48M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -10.59M | -10.37M | -12.91M | -11.29M | -9.48M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -10.59M | -10.37M | -12.91M | -11.29M | -9.48M |
|